Mana Taki

1.5k total citations · 1 hit paper
46 papers, 1.0k citations indexed

About

Mana Taki is a scholar working on Oncology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Mana Taki has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Obstetrics and Gynecology and 11 papers in Reproductive Medicine. Recurrent topics in Mana Taki's work include Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Mana Taki is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Mana Taki collaborates with scholars based in Japan, United States and Canada. Mana Taki's co-authors include Noriomi Matsumura, Masaki Mandai, Ken Yamaguchi, Junzo Hamanishi, Tsukasa Baba, Kaoru Abiko, Ryusuke Murakami, Koji Yamanoi, Yuko Hosoe and Masayo Ukita and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Mana Taki

35 papers receiving 1.0k citations

Hit Papers

Tumor Immune Microenvironment during Epithelial–Mesenchym... 2021 2026 2022 2024 2021 50 100 150 200

Peers

Mana Taki
Behrouz Zand United States
Corrine Zarwan United States
Suha Deen United Kingdom
Paolo Cotzia United States
Mana Taki
Citations per year, relative to Mana Taki Mana Taki (= 1×) peers Mahiru Kawano

Countries citing papers authored by Mana Taki

Since Specialization
Citations

This map shows the geographic impact of Mana Taki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mana Taki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mana Taki more than expected).

Fields of papers citing papers by Mana Taki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mana Taki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mana Taki. The network helps show where Mana Taki may publish in the future.

Co-authorship network of co-authors of Mana Taki

This figure shows the co-authorship network connecting the top 25 collaborators of Mana Taki. A scholar is included among the top collaborators of Mana Taki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mana Taki. Mana Taki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murakami, Ryusuke, Koji Yamanoi, Taito Miyamoto, et al.. (2025). Real-world application of large language models for automated TNM staging using unstructured gynecologic oncology reports. npj Precision Oncology. 9(1). 366–366.
2.
Hamanishi, Junzo, Akihiko Ueda, Ryusuke Murakami, et al.. (2025). Artificial intelligence-based spatial analysis of tertiary lymphoid structures and clinical significance for endometrial cancer. Cancer Immunology Immunotherapy. 74(3). 84–84. 1 indexed citations
3.
Yamaguchi, Ken, Naoki Horikawa, Yasushi Kotani, et al.. (2025). Prognostic significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in uterine carcinosarcoma. International Journal of Clinical Oncology. 30(3). 570–583. 2 indexed citations
4.
Murakami, Ryusuke, Akihiko Ueda, Mana Taki, et al.. (2024). A Deep Learning–Based Assessment Pipeline for Intraepithelial and Stromal Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Carcinoma. American Journal Of Pathology. 194(7). 1272–1284. 4 indexed citations
5.
Yamaguchi, Ken, Koji Yamanoi, Shiro Takamatsu, et al.. (2024). YAP1 Suppression by ZDHHC7 Is Associated with Ferroptosis Resistance and Poor Prognosis in Ovarian Clear Cell Carcinoma. Molecular Cancer Therapeutics. 23(11). 1652–1665. 7 indexed citations
6.
Yamanoi, Koji, Eijiro Nakamura, Shinji Ito, et al.. (2024). A stearate-rich diet and oleate restriction directly inhibit tumor growth via the unfolded protein response. Experimental & Molecular Medicine. 56(12). 2659–2672. 5 indexed citations
7.
Yamaguchi, Ken, Sachiko Tanaka‐Mizuno, Mana Taki, et al.. (2024). Changes in Physical Activity Across Cancer Diagnosis and Treatment Based on Smartphone Step Count Data Linked to a Japanese Claims Database: Retrospective Cohort Study. JMIR Cancer. 11. e58093–e58093. 1 indexed citations
8.
Yamaguchi, Ken, Akihiko Ueda, Mana Taki, et al.. (2024). Electronic patient-reported outcomes as digital therapeutics for patients with cancer: a narrative review of current practices and future directions. International Journal of Clinical Oncology. 30(1). 1–16. 2 indexed citations
9.
Taki, Mana, Koichi Watanabe, Koji Yamanoi, et al.. (2024). A case report of mucinous borderline ovarian tumor with recurrence as invasive carcinoma with high copy number alterations. International Cancer Conference Journal. 13(4). 520–524. 1 indexed citations
10.
Yamanoi, Koji, Yasushi Kotani, Hisanori Matsumoto, et al.. (2024). Real-world application of comprehensive genomic profiling for gynecological malignancies: a multicenter observational study. International Journal of Clinical Oncology. 29(12). 1967–1976. 1 indexed citations
11.
Watanabe, Koichi, Koji Yamanoi, Nobuyuki Kakiuchi, et al.. (2024). Origin of Peritoneal Cancer With Features of High-grade Serous Carcinoma: A Detailed Molecular Analysis. International Journal of Gynecological Pathology. 44(3). 280–285.
12.
Koyama, Misaki, Ken Yamaguchi, Yoshitsugu Chigusa, et al.. (2023). ATM mutation in aggressive uterine adenosarcoma in which systemic chemotherapies had remarkable effects. International Cancer Conference Journal. 12(2). 120–125. 2 indexed citations
13.
Watanabe, Koichi, Nobuyuki Kakiuchi, Shiro Takamatsu, et al.. (2023). Abstract 128: Clonal expansion with driver mutations in normal human endometrium. Cancer Research. 83(7_Supplement). 128–128.
15.
Yamaguchi, Ken, Yosuke Yamamoto, Akihiko Ueda, et al.. (2022). Development of healthy lifestyle consciousness index for gynecological cancer patients. Supportive Care in Cancer. 30(9). 7569–7574. 1 indexed citations
16.
Murakami, Ryusuke, Junzo Hamanishi, J.B. Brown, et al.. (2021). Combination of gene set signatures correlates with response to nivolumab in platinum-resistant ovarian cancer. Scientific Reports. 11(1). 11427–11427. 4 indexed citations
17.
Horikawa, Naoki, Kaoru Abiko, Noriomi Matsumura, et al.. (2020). Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment. British Journal of Cancer. 122(6). 778–788. 72 indexed citations
18.
Gotoh, Osamu, Yuko Sugiyama, Yutaka Takazawa, et al.. (2019). Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma. Nature Communications. 10(1). 4965–4965. 89 indexed citations
19.
Hamanishi, Junzo, Noriomi Matsumura, Kenji Chamoto, et al.. (2018). VISTA expressed in tumour cells regulates T cell function. British Journal of Cancer. 120(1). 115–127. 155 indexed citations
20.
Taki, Mana, Yukiyasu Sato, Kazuyo Kakui, et al.. (2011). Management of fetal death with placenta previa. The Journal of Maternal-Fetal & Neonatal Medicine. 25(2). 196–199. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026